IMS Country Review 2015: Greece

  • ID: 1408505
  • July 2015
  • Region: Greece
  • 69 pages
  • IMS Health
1 of 3

IMS Country Review provides comprehensive qualitative insights into a specific pharmaceutical market as well as showing sales trends over the last 5 years.

Sales performance is analysed in terms of major corporations, therapeutic classes, major products and new product activity.

Key Benefits:

- Targeted national sales analysis by company, product and therapy areas, allowing you to understand the pharmaceutical performance of the country.
- Synopsis of the healthcare system and relevant pharmaceutical issues, based on primary research gathered by the IMS country experts.
- Standardised comparable data against which the industry is measured, stemming from accurate and reliable IMS audited year-end sales data.

Includes useful measures:
- US$ sales
- 5 year growth in US $ and local currency dollar (eliminating inaccuracies due to exchange rate fluctuations)
- Evolution Index
- market share
- Detailed information file allowing a thorough understanding of the data values and definitions, the universe/country abbreviations, and the EphMRA anatomical therapeutic classification
- Cost-effective strategic analysis tool that will provide the essential insights needed to get insights into a country market of interest

Note: Product cover images may vary from those shown
2 of 3

IMS Country Review comprises 2 sections:

1. Qualitative country overview, featuring consistent sections on:
- Market Trends
- Healthcare Provision
- Prescribing Policy
- Pricing System
- Regulatory Environment
- Industr y Environment
- Channels of Distr ibution

2. Quantitative country performance sections, providing sales trends for:
- Country ranking amongst 40 markets
- Audited Market Trend
- Leading 35 local companies
- Leading 35 corporations
- Market Share by Corporate Nationality
- Leading 15 Therapeutic Classes
- 15 Fastest-Growing Therapeutic Classes
- Leading 15 Therapeutic Class Profiles, including trends for top 10 corporations and top 10 products
- Leading 40 Products
- Leading 40 New Products
- Leading 15 product forms

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.


If you have a more general question about our products please try our



Our Clients

  • Pfizer, Inc.
  • Grünenthal GmbH
  • GlaxoSmithKline PLC
  • Abbott Laboratories Ltd.
  • Roche Diagnostics Ltd.
  • Novo Nordisk A/S